EP3454893A4 - Composition comprenant des antigènes et un adjuvant pour les muqueuses et méthode d'utilisation - Google Patents

Composition comprenant des antigènes et un adjuvant pour les muqueuses et méthode d'utilisation Download PDF

Info

Publication number
EP3454893A4
EP3454893A4 EP16901833.0A EP16901833A EP3454893A4 EP 3454893 A4 EP3454893 A4 EP 3454893A4 EP 16901833 A EP16901833 A EP 16901833A EP 3454893 A4 EP3454893 A4 EP 3454893A4
Authority
EP
European Patent Office
Prior art keywords
antigens
composition
mucosal adjuvant
mucosal
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16901833.0A
Other languages
German (de)
English (en)
Other versions
EP3454893A1 (fr
Inventor
Grant WEAVER
Jeff KULA
Boh Chang LIN
Karen Brown
Wesley W. JOHNSON
Michael Dennis MURPHY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phibro Animal Health Corp
Original Assignee
Phibro Animal Health Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phibro Animal Health Corp filed Critical Phibro Animal Health Corp
Publication of EP3454893A1 publication Critical patent/EP3454893A1/fr
Publication of EP3454893A4 publication Critical patent/EP3454893A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP16901833.0A 2016-05-11 2016-05-11 Composition comprenant des antigènes et un adjuvant pour les muqueuses et méthode d'utilisation Withdrawn EP3454893A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/031902 WO2017196318A1 (fr) 2016-05-11 2016-05-11 Composition comprenant des antigènes et un adjuvant pour les muqueuses et méthode d'utilisation

Publications (2)

Publication Number Publication Date
EP3454893A1 EP3454893A1 (fr) 2019-03-20
EP3454893A4 true EP3454893A4 (fr) 2020-01-01

Family

ID=60267492

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16901833.0A Withdrawn EP3454893A4 (fr) 2016-05-11 2016-05-11 Composition comprenant des antigènes et un adjuvant pour les muqueuses et méthode d'utilisation

Country Status (3)

Country Link
EP (1) EP3454893A4 (fr)
CA (1) CA3022006A1 (fr)
WO (1) WO2017196318A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112457397A (zh) * 2020-11-26 2021-03-09 西北农林科技大学 一种prrsv n蛋白的纳米抗体及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001025A2 (fr) * 1998-10-22 2000-05-17 Pfizer Products Inc. Protéines principales de la membrane externe de actinobacillus pleuropneumoniae
US20110123570A1 (en) * 2009-11-10 2011-05-26 Boehringer Ingelheim Vetmedica, Inc. Actinobacillus suis antigens
WO2014004361A1 (fr) * 2012-06-27 2014-01-03 Merial Limited Vaccins atténués contre le streptococcus suis et leurs procédés de fabrication et d'utilisation
CN104511015A (zh) * 2013-09-30 2015-04-15 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法与应用
CN110075289A (zh) * 2019-04-19 2019-08-02 河南省农业科学院畜牧兽医研究所 一种副猪嗜血杆菌、猪链球菌与胸膜肺炎放线杆菌三联灭活疫苗及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5393978B2 (ja) * 2004-04-05 2014-01-22 ゾエティス・ピー・エルエルシー マイクロ流動化された水中油型乳剤及びワクチン組成物
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
WO2009134769A1 (fr) * 2008-04-28 2009-11-05 Novartis Ag Nanoparticules destinées à être utilisées dans des compositions pharmaceutiques
WO2012110489A2 (fr) * 2011-02-17 2012-08-23 Boehringer Ingelheim Vetmedica Gmbh Nouvelle souche de prrsv européenne
WO2012145573A2 (fr) * 2011-04-21 2012-10-26 Universiteit Utrecht Holding Bv Lysines des bactériophages de streptocoques pour le traitement de bactéries à gram positif chez les animaux de compagnie et chez le bétail

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001025A2 (fr) * 1998-10-22 2000-05-17 Pfizer Products Inc. Protéines principales de la membrane externe de actinobacillus pleuropneumoniae
US20110123570A1 (en) * 2009-11-10 2011-05-26 Boehringer Ingelheim Vetmedica, Inc. Actinobacillus suis antigens
WO2014004361A1 (fr) * 2012-06-27 2014-01-03 Merial Limited Vaccins atténués contre le streptococcus suis et leurs procédés de fabrication et d'utilisation
CN104511015A (zh) * 2013-09-30 2015-04-15 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法与应用
CN110075289A (zh) * 2019-04-19 2019-08-02 河南省农业科学院畜牧兽医研究所 一种副猪嗜血杆菌、猪链球菌与胸膜肺炎放线杆菌三联灭活疫苗及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MAYANK CHATURVEDI ET AL: "A review on mucoadhesive polymer used in nasal drug delivery system", JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, vol. 2, no. 4, 1 October 2011 (2011-10-01), pages 215 - 222, XP055232682, DOI: 10.4103/2231-4040.90876 *
See also references of WO2017196318A1 *
SHARAD MANGAL ET AL: "Evaluation of mucoadhesive carrier adjuvant: Toward an oral anthrax vaccine", ARTIFICIAL CELLS, NANOMEDICINE AND BIOTECHNOLOGY, vol. 42, no. 1, 1 February 2014 (2014-02-01), US, pages 47 - 57, XP055645252, ISSN: 2169-1401, DOI: 10.3109/21691401.2013.769447 *
WANG SHUJING ET AL: "Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies", PROTEIN & CELL, SPRINGER ASIA, BEIJING, CN, vol. 6, no. 7, 6 May 2015 (2015-05-06), pages 480 - 503, XP035507308, ISSN: 1674-800X, [retrieved on 20150506], DOI: 10.1007/S13238-015-0164-2 *

Also Published As

Publication number Publication date
CA3022006A1 (fr) 2017-11-16
EP3454893A1 (fr) 2019-03-20
WO2017196318A1 (fr) 2017-11-16

Similar Documents

Publication Publication Date Title
EP3378488A4 (fr) Procédé pour renforcer la réponse immunitaire humorale
EP3499367A4 (fr) Procédé et dispositif de démarrage d'une application
EP3521511A4 (fr) Feuille désintégrable dans l'eau et procédé de production de la feuille désintégrable dans l'eau
EP3484508A4 (fr) Compositions et procédés pour la vaccination contre les alphavirus
EP3410296A4 (fr) Procédé et dispositif de démarrage pour dispositif intégré
EP3273950A4 (fr) Compositions adjuvantes et méthodes associées
EP3345761A4 (fr) Feuille décorative et procédé de fabrication de feuille décorative
EP3200831A4 (fr) Vaccins possédant un antigène et une interleukine-21 en tant qu'adjuvant
EP3385286A4 (fr) Antigène vaccinal à immunogénicité accrue
EP3240664A4 (fr) Procédé et appareil pour former des pierres artificielles
EP3416681A4 (fr) Nouvel antigène destiné à être utilisé dans un vaccin antipaludique
EP3505038A4 (fr) Feuille désintégrable dans l'eau et procédé de production de feuille pouvant se désintégrer dans l'eau
EP3131579A4 (fr) Compositions d'adjuvants de vaccins
EP3730620A4 (fr) Vaccin antigénique à immunisation croisée et son procédé de préparation
EP3456324A4 (fr) Procédé de fabrication de préparation d'acétaminophène
EP3740497A4 (fr) Immunogénicité améliorée pour des antigènes ancrés au gpi
EP3451393A4 (fr) Élément électroluminescent et son procédé de fabrication
EP3600399A4 (fr) Procédés et compositions pour vacciner contre le paludisme
EP3176811A4 (fr) Composition de film sacrificiel, son procédé de préparation, dispositif à semi-conducteur présentant des vides formés au moyen de ladite composition, et procédé de fabrication de dispositif à semi-conducteur au moyen de ladite composition
EP3677548A4 (fr) Procédé de fabrication de nano-sio2 ultra-poreux
EP3509988A4 (fr) Graphène multi-dopé et son procédé de préparation
EP3223846A4 (fr) Compositions d'adjuvant et procédés associés
EP3104418B8 (fr) Procédé et dispositif destinés à texturer une surface en silicium
EP3766869A4 (fr) Procédé simple de préparation d'avibactam
EP3434494A4 (fr) Procédé de formation d'image

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181026

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20191204

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/09 20060101ALI20191128BHEP

Ipc: A61K 39/02 20060101AFI20191128BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220429

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20221005